The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Noninvasive detection of clinically relevant copy number alterations in diffuse large B-cell lymphoma.
 
Michael C. Jin
No Relationships to Disclose
 
David Matthew Kurtz
No Relationships to Disclose
 
Mohammad Shahrokh Esfahani
No Relationships to Disclose
 
Florian Scherer
No Relationships to Disclose
 
Alexander F.M. Craig
No Relationships to Disclose
 
Joanne Soo
No Relationships to Disclose
 
Michael Siavash Khodadoust
No Relationships to Disclose
 
Ruth Sharon Saganty
No Relationships to Disclose
 
Jacob J. Chabon
No Relationships to Disclose
 
Joseph Schroers-Martin
No Relationships to Disclose
 
Henning Stehr
No Relationships to Disclose
 
Ranjana H. Advani
Consulting or Advisory Role - Bristol-Myers Squibb; Forty Seven; Genentech/Roche; Gilead Sciences; NanoString Technologies; Pharmacyclics; Spectrum Pharmaceuticals; Sutter Medical Group
Research Funding - Agensys (Inst); Celgene (Inst); Genentech/Roche (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Kura Oncology (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Regeneron (Inst); Seagen (Inst)
 
Davide Rossi
No Relationships to Disclose
 
Gianluca Gaidano
No Relationships to Disclose
 
Jason R. Westin
Consulting or Advisory Role - Celgene; Genentech/Abbvie; Kite, a Gilead company; Novartis; ProNAi; Spectrum Pharmaceuticals
Research Funding - Celgene; Genentech; Janssen; Karyopharm Therapeutics; ProNAi
 
Maximilian Diehn
Stock and Other Ownership Interests - CAPP Medical; CiberMed; Quanticel Pharma
Consulting or Advisory Role - Quanticel Pharma; Roche
Research Funding - Varian Medical Systems
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection assigned to Stanford University (Inst); Patent filings on tumor treatment resistance mechanisms assigned to Stanford University (Inst)
Travel, Accommodations, Expenses - Roche; Varian Medical Systems
 
Ash A. Alizadeh
Leadership - Lymphoma Research Foundation
Stock and Other Ownership Interests - CAPP Medical; CiberMed
Honoraria - Roche
Consulting or Advisory Role - Celgene; Gilead Sciences; Roche/Genentech
Research Funding - Celgene
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection, assigned to Stanford University. (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche